Related Experiment Videos

Impaired glucose transport in polymorphonuclear leukocytes in glycogen storage disease Ib

N Bashan1, R Potashnik, Y Hagay

  • 1Pediatric Research Laboratory, Soroka Medical Center, Beer Sheva, Israel.

Insights

Patients with glycogen storage disease (GSD) type Ib exhibit impaired 2-deoxyglucose transport in polymorphonuclear leukocytes (PMN). This cellular defect in glucose uptake may explain the characteristic leukocyte dysfunction seen in GSD Ib.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Glycogen storage disease (GSD) type Ib is a rare metabolic disorder.
  • Leukocyte dysfunction is a hallmark of GSD Ib, but its underlying mechanisms are not fully understood.
  • Glucose transport is crucial for cellular energy metabolism and immune cell function.

Purpose of the Study:

  • To investigate the rate of 2-deoxyglucose transport in polymorphonuclear leukocytes (PMN) from patients with GSD type Ib.
  • To determine if impaired glucose transport contributes to the leukocyte dysfunction observed in GSD Ib.
  • To explore the kinetic parameters of glucose transport in GSD Ib PMN.

Main Methods:

  • Studied 2-deoxyglucose transport in PMN and lymphocytes from three GSD Ib patients.
  • Compared glucose transport rates and Michaelis constant (Km) with normal controls.
  • Assessed 2-deoxyglucose phosphorylation rates.

Main Results:

  • PMN from GSD Ib patients showed a 70% reduction in 2-deoxyglucose transport compared to normal controls.
  • Glucose transport in GSD Ib lymphocytes was found to be normal.
  • The reduced transport rate was not attributed to altered Km or phosphorylation of 2-deoxyglucose.

Conclusions:

  • A significant impairment in glucose transport across the cell membrane exists in PMN of GSD Ib patients.
  • This defect in glucose uptake is a likely cause of the impaired leukocyte function characteristic of GSD Ib.
  • Further research into glucose transporter function in GSD Ib is warranted.

Related Concept Videos